Camille Molloy, an ovarian cancer patient, had an extraordinary response to a novel precision treatment being tested in a phase 1 clinical trial at Dana-Farber. The Center for Cancer Therapeutic Innovation runs phase 1 clinical trials at Dana-Farber and matches the right patients to the right opportunities to try novel therapies. Thanks to Camille’s courage and participation, this therapy will continue to be tested and could help others with ovarian cancer. Learn more: [ Ссылка ]
